Search Results for: hemophilic arthropathy

TRM-201 (Rofecoxib)

TRM-201 (rofecoxib) is an investigational treatment being developed by Tremeau Pharmaceuticals for severe joint disease in patients with hemophilia. Known as hemophilic arthropathy, or permanent joint disease, it is a long-term consequence ... Read more